[ad_1]

(MENAFN- Caribbean Information Global)

NEW YORK–(Company WIRE)–On Thursday, June 16, 2022, a lot more than 900 people from about 100 companies from the leveraged finance and non-public fairness communities arrived jointly for the Leveraged Finance Fights Melanoma (LFFM) profit and cocktail bash. Hosted at the Museum of Modern day Artwork, the function raised a document breaking $3 million for the Melanoma Analysis Alliance’s (MRA) mission to progress the world’s most modern and promising melanoma analysis.

“Each 12 months, I go on to be impressed by the community’s response to this occasion and the mission it supports,” suggests LFFM co-founder and MRA board member Jeff Rowbottom.“LFFM has develop into a signature occasion for the finance marketplace, and it plays a significant part in advancing most cancers exploration that is virtually preserving life, like mine.”

LFFM funding supports chopping-edge melanoma investigate that has assisted sufferers with all styles of cancer are living longer, fuller life. Solutions initial pioneered in melanoma are now becoming used to treat sufferers with more than 30 other most cancers sorts.

LFFM was launched in 2011 by Jeff Rowbottom (Iron Park Funds) and Brendan Dillon (Veritas Funds) – both equally melanoma survivors. Because its founding, LFFM has raised much more than $19 million for MRA, the greatest nonprofit funder of melanoma exploration. Because its founding in 2007, MRA-funded investigators have been deeply involved in every breakthrough in melanoma research, including the approval of 15 new therapies.

The party was co-chaired by Clare Bailhé (MidCap Fiscal), Brendan Dillon (Veritas Money), Kerry Dolan (Brinley Partners), Lee Grinberg (Elliott Management), Matt Manin (Apollo), George Mueller (KKR), Geoff Oltmans (Silver Lake), Kevin Pluff , Jeff Rowbottom (Iron Park Cash), Ian Schuman (Latham & Watkins), Cade Thompson (KKR), Trevor Watt (Hellman & Friedman), and Eric Wedel (Kirkland & Ellis).

Presenting sponsors of the event provided Latham & Watkins, Kirkland & Ellis, Simpson Thacher & Bartlett, Fitch Scores, Michael Milken, HPS Investment decision Companions, Apollo|Midcap, Iron Park Capital Administration, Veritas Money Management and White & Case. A comprehensive listing of LFFM sponsors is provided down below.

“The leveraged finance and personal fairness communities are some of the greatest advocates for MRA and our mission to remedy melanoma,” suggests MRA CEO Marc Hurlbert, PhD.“The funds elevated from this function will even further accelerate the MRA exploration agenda and the continuation of faster cures, new treatment options and lifesaving breakthroughs.

LFFM 2022 Sponsors

PRESENTING

Kirkland & Ellis

Latham & Watkins

Simpson Thacher & Bartlett LLP

Michael Milken

Apollo|Midcap

Fitch Scores

HPS Investment Companions, LLC

Iron Park Money

Veritas Cash Management LLC

White & Case LLP

PLATINUM

Allen & Overy

BMO Cash Markets

Davis Polk & Wardwell

Joyce and Barry Cohen

Shearman & Sterling LLP

Sidley Austin LLP

UBS Fiscal

GOLD

Bank of America Merrill Lynch

Barclays Money

Bloomberg L.P.

Brinley Partners

Citi

Standard Atlantic Philanthropic Foundation

Golub Capital

Hellman & Friedman

Intesa Sanpaolo

King & Spalding LLP

KKR

Leonard Green & Associates

Howard and Nancy Marks

Milbank LLP

MJR Foundation

Morgan Stanley

New Mountain Finance Company

Proskauer Rose

Ropes & Grey LLP

Silver Lake

Sixth Avenue Companions

Skadden, Arps, Slate, Meagher & Flom LLP

T. Rowe Value

TD Securities

The Carlyle Group

Thoma Bravo

Vista Fairness Partners

Weil, Gotshal & Manges LLP

Wells Fargo Bank

Preferred

Jefferies LLC

Credit Suisse

GTCR

Royal Lender of Canada/RBC Cash Markets

American Industrial Associates

Ares Administration LLC

BC Companions

Blackstone Credit history

Blue Owl Funds

BNP Paribas

Centerbridge Companions

Clayton, Dubilier & Rice LLC

Cleary Gottlieb Steen & Hamilton

Cravath, Swaine & Moore LLP

Debevoise & Plimpton

Deutsche Financial institution

Fried, Frank, Harris, Shriver & Jacobson LLP

HIG Capital

HSBC Bank

Macquarie Team

Madison Dearborn Associates

Matt Nord and Erika Weinberg

Mizuho Securities United states of america, Inc.

MJX Asset Management LLC

MUFG

Oak Hill Advisors, LP

Oak Hill Funds Management

Silver Rock Economical

Stone Canyon Industries

Stone Issue Money

Sullivan & Cromwell LLP

Wachtell, Lipton, Rosen & Katz

Winston & Strawn

ADVOCATE

Fortinbras

Tiger International

Advent International Corporation

Angelo Gordon & Co.

BlackRock

Brookfield Asset Management

Capital A person Bank

Clarion Capital Partners, LLC

GoldenTree Asset Administration, LP

Lauren Hanrahan

Houlihan Lokey

LSTA

Natixis

Orchard First Source Asset Management

Paul Hastings LLP

PNC Financial institution

Riverstone

Rothschild & Co.

Seix Investment decision Advisors

Shenkman Money Administration Inc.

Siris Cash Team

Stonepeak Partners

Sumitomo Mitsui Banking Corporation (SMBC)

Stephanie Teicher

Warburg Pincus LLC

Z Money Group

About Melanoma Analysis Alliance (MRA)

The Melanoma Research Alliance (MRA) stands as the greatest non-income funder of melanoma research. Established in 2007, MRA’s mission is to finish struggling and dying because of to melanoma by advancing the world’s most promising science and investigation. MRA provides critical funding for melanoma cancer study that propels advancements in avoidance, analysis, treatment, metastasis, and survivorship. MRA-funded scientists have been powering every single breakthrough in melanoma research. Considering the fact that MRA’s inception, more than 15 new therapeutic ways for melanoma have gained Food and drug administration approval. MRA is regarded as one particular of the most fiscally efficient non-profits in the nation. Mainly because MRA’s Founders’ generously protect 100% of MRA’s administrative and working expenses, each individual dollar donated is invested straight into MRA’s scientific and research system. For much more facts, please check out: .

LinkedIn: melanoma-study-alliance

Twitter: @MelanomaReAlli

Instagram: @melanoma

Facebook: MelanomaResearchAlliance

Contacts

Cody R. Barnett, Director of Communications

M: (717) 880-7100

E-mail:

Added Media Contacts:
Anreder & Corporation

917.923.7011
Steven S. Anreder —
Michael Wichman —

MENAFN17062022000232011072ID1104392577

&#13
Legal Disclaimer: MENAFN delivers the information and facts “as is” without the need of warranty of any variety. We do not accept any duty or liability for the precision, articles, visuals, movies, licenses, completeness, legality, or reliability of the data contained in this article. If you have any complaints or copyright concerns related to this post, kindly make contact with the service provider above. &#13

[ad_2]

Supply url